NCT07286266
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07286266
Title A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)
Acronym BEHOLD-Ovarian01
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR | CAN | AUS

Facility Status City State Zip Country Details
GSK Investigational Site RECRUITING Randwick New South Wales 2031 Australia Details
GSK Investigational Site RECRUITING Auchenflower Queensland 4066 Australia Details
GSK Investigational Site RECRUITING Toronto Ontario M5G 1Z5 Canada Details
GSK Investigational Site RECRUITING Montreal Quebec H2X 0C1 Canada Details
GSK Investigational Site RECRUITING Montreal Quebec H4A 3J1 Canada Details
GSK Investigational Site RECRUITING Fukuoka 811-1395 Japan Details
GSK Investigational Site RECRUITING Fukuoka 830-0011 Japan Details
GSK Investigational Site RECRUITING Hokkaido 060-8648 Japan Details
GSK Investigational Site RECRUITING Hyōgo 673-8558 Japan Details
GSK Investigational Site RECRUITING Kanagawa 216-8511 Japan Details
GSK Investigational Site RECRUITING Kanagawa 241-8515 Japan Details
GSK Investigational Site RECRUITING Mie 514-8507 Japan Details
GSK Investigational Site RECRUITING Okinawa 901-2725 Japan Details
GSK Investigational Site RECRUITING Osaka 569-8686 Japan Details
GSK Investigational Site RECRUITING Saitama 350-1298 Japan Details
GSK Investigational Site RECRUITING Tottori 683-8504 Japan Details
GSK Investigational Site RECRUITING Seoul Seoul Teugbyeolsi 06351 South Korea Details
GSK Investigational Site RECRUITING Gyeonggi-do 10408 South Korea Details
GSK Investigational Site RECRUITING Seoul 03722 South Korea Details
GSK Investigational Site RECRUITING Seoul 05505 South Korea Details
GSK Investigational Site RECRUITING Suwon Kyunggi-do 443-380 South Korea Details
GSK Investigational Site RECRUITING London NW1 2BU United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field